GWSG
PACB icon

GPS Wealth Strategies Group’s Pacific Biosciences PACB Stock Holding History

GPS Wealth Strategies Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-511
Closed -$634 – 1699
2025
Q2 		$634 Hold
511
– – ﹤0.01% 1463
2025
Q1 		$603 Hold
511
– – ﹤0.01% 1395
2024
Q4 		$935 Hold
511
– – ﹤0.01% 1302
2024
Q3 		$869 Hold
511
– – ﹤0.01% 1301
2024
Q2 		$700 Hold
511
– – ﹤0.01% 1288
2024
Q1 		$1.92K Hold
511
– – ﹤0.01% 1133
2023
Q4 		$5.01K Hold
511
– – ﹤0.01% 980
2023
Q3 		$4.27K Hold
511
– – ﹤0.01% 995
2023
Q2 		$6.8K Buy
+511
New +$6.21K ﹤0.01% 915

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

GPS Wealth Strategies Group's PACB Position: Q3 2025 in Review

GPS Wealth Strategies Group sold out of Pacific Biosciences (PACB) in Q3 2025, closing a stake of 511 shares — an estimated $634 sold.

GPS Wealth Strategies Group first reported a position in PACB in Q2 2023 and held it in 9 quarters. The position peaked at $6.8K in Q2 2023. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

  • GPS Wealth Strategies Group reported no remaining Pacific Biosciences position as of Q3 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 511 Pacific Biosciences shares in Q3 2025, an estimated $634.
  • GPS Wealth Strategies Group first reported a position in Pacific Biosciences in Q2 2023 and held it in 9 quarters.
  • GPS Wealth Strategies Group's Pacific Biosciences position peaked at $6.8K in Q2 2023.
  • 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2025, filed 3 Nov 2025.